Home Newsfeeds UBS Maintains Buy on CareMax, Lowers Price Target to $6

UBS Maintains Buy on CareMax, Lowers Price Target to $6

UBS analyst Andrew Mok maintains CareMax (NASDAQ:CMAX) with a Buy and lowers the price target from $10 to $6.

byBenzinga Newsdesk

January 6, 2023

1 minute read

UBS analyst Andrew Mok maintains CareMax (NASDAQ:CMAX) with a Buy and lowers the price target from $10 to $6.

Semiconductor Surge: JPMorgan Bets AMD, Micron, Arm Will Drive Industry Optimism And AI Demand

By Surbhi Jain

May 23, 12:09 PM

Semiconductor industry entering upcycle, demand for AI and accelerated compute strengthening. Optimism about revenue prospects and cyclical improvements.

ALAB

Wells Fargo Maintains Overweight on United Parcel Service, Lowers Price Target to $207

By Benzinga Newsdesk

October 26, 8:09 AM

Wells Fargo analyst Allison Poliniak Cusic maintains United Parcel Service (NYSE:UPS) with a Overweight and lowers the price target from $223 to $207.

UPS